These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24350680)

  • 1. Analysis of covalent modifications of proteins by oxidized phospholipids using a novel method of peptide enrichment.
    Gao D; Willard B; Podrez EA
    Anal Chem; 2014 Jan; 86(2):1254-62. PubMed ID: 24350680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
    Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe.
    Szapacs ME; Kim HY; Porter NA; Liebler DC
    J Proteome Res; 2008 Oct; 7(10):4237-46. PubMed ID: 18778096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-line high speed lipid extraction for nanoflow liquid chromatography-tandem mass spectrometry.
    Lee JY; Yang JS; Park SM; Byeon SK; Moon MH
    J Chromatogr A; 2016 Sep; 1464():12-20. PubMed ID: 27530420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophilic interaction liquid chromatography-electrospray ionization-tandem mass spectrometry of a complex mixture of native and oxidized phospholipids.
    Losito I; Facchini L; Diomede S; Conte E; Megli FM; Cataldi TRI; Palmisano F
    J Chromatogr A; 2015 Nov; 1422():194-205. PubMed ID: 26508677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins.
    Demoor L; Boutillon C; Fievet C; Vanloo B; Baert J; Rosseneu M; Fruchart JC; Tartar A
    Eur J Biochem; 1996 Jul; 239(1):74-84. PubMed ID: 8706721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
    Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
    Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.
    Ravandi A; Leibundgut G; Hung MY; Patel M; Hutchins PM; Murphy RC; Prasad A; Mahmud E; Miller YI; Dennis EA; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2014 May; 63(19):1961-71. PubMed ID: 24613321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Method for Analysis of Oxidized Phospholipids from Biological Samples Using Mass Spectrometry.
    Ghorasaini M; Costa D; Tyrrell VJ; Protty M; Giera M; O'Donnell VB
    Methods Mol Biol; 2025; 2855():155-169. PubMed ID: 39354307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidized phospholipids analysis by LC-MS/MS.
    Khoury S; Pouyet C; Lyan B; Pujos-Guillot E
    Anal Bioanal Chem; 2018 Jan; 410(2):633-647. PubMed ID: 29184993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.